Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression [scRNA-Seq]

ABSTRACT: To characterize the immune landscape of colorectal tumors, we analysed the immune tumor microenvironment cells from mice bearing orthotopic tumors using single cell transcriptomics.

ORGANISM(S): Mus musculus

PROVIDER: GSE231803 | GEO | 2024/06/21

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression [bulkRNA-Seq]

Project description:To examine the mechanisms by which EGCs affect the immune CRC compartment with particular regard to the TAMs, we first investigated their transcriptional adaptations upon CRC onset. To this end, we established an in vitro setup to study EGC-CRC interactions able to mimic the response of EGCs to the factors secreted by the TME. These EGCs, from now onwards defined as TME-conditioned medium-treated EGCs (TME-CM EGCs), were generated by stimulating primary EGCs with the CM of digested murine MC38 orthotopic tumor tissues (Figure 2A). Bulk RNA sequencing (RNA-seq) was performed to determine transcriptional differences in TME-CM EGCs, compared to unstimulated and healthy conditioned medium-treated (H-CM) primary EGCs, at different time points.

2024-06-21 | GSE231802 | GEO

IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-06-20 | GSE231804 | GEO

IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

Project description:To investigate the effect of transcriptomic changes in colorectal cancer, we performed 3' bulk mRNA sequencing of naive and AOM/DSS treated mice. Mice were subjected to the AOM/DSS mouse model for colorectal cancer or kept under naive conditions. Samples of the most distal 0.5 cm of the colon were taken on day 70 of the model and processed for 3' bulk mRNA sequencing.

2024-06-05 | GSE231709 | GEO

IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression [bulkRNA-Seq]

Project description:IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression [bulkRNA-Seq]

| PRJNA967709 | ENA

IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression [scRNA-Seq]

Project description:IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression [scRNA-Seq]

| PRJNA967710 | ENA

IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

Project description:IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

| PRJNA967330 | ENA

IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

Project description:IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

| PRJNA967708 | ENA

Phosphoproteomic analysis of IL-2 MSA and IL-12 MSA combination on T cell signaling

Project description:Engineered cytokine-based approaches for immunotherapy of cancer are poised to enter the clinic, with IL-12 being at the forefront. However, little is known about potential mechanisms of resistance to cytokine therapies. We found that orthotopic murine lung tumors were resistant to systemically delivered IL-12 fused to murine serum albumin (MSA, IL12-MSA) due to low IL-12R expression on tumor-reactive CD8+ T cells. IL2-MSA increased binding of IL12-MSA by tumor-reactive CD8+ T cells, and combined administration of IL12-MSA and IL2-MSA led to enhanced tumor-reactive CD8+ T cell effector differentiation, decreased numbers of tumor-infiltrating CD4+ regulatory T (Treg) cells, and increased survival of lung tumor-bearing mice. Predictably, the combination of IL-2 and IL-12 at therapeutic doses led to significant dose-limiting toxicity. Administering IL-12 and IL-2 analogs with preferential binding to cells expressing IL12rb1 and CD25, respectively, led to a significant extension of survival in mice with lung tumors while abrogating dose-limiting toxicity. These findings suggest that IL-12 and IL-2 represent a rational approach to combination cytokine therapy whose dose-limiting toxicity can be overcome with engineered cytokine variants.

2024-01-26 | PXD044740 | Pride

Project description:MRX34 Biomarker study in animals bearing Hep3B orthotopic liver tumors

| PRJNA253821 | ENA

Type I IFN Signaling Drives Responsiveness to Short Course Radiotherapy in a Murine Model of Rectal Cancer

Project description:Specific cell types from orthotopic murine rectal tumors were sequenced to explore the effect that short course radiotherapy has on the immune response.

2023-08-07 | GSE227738 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data